<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Gilley SP</submitter><funding>Eunice Kennedy Shriver National Institute of Child Health and Human Development</funding><funding>NICHD NIH HHS</funding><funding>U.S. Department of Agriculture</funding><funding>Gates Foundation</funding><funding>USDA Agricultural Research Service</funding><pagination>101279</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12863136</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>156(2)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Maternal selenium deficiency is hypothesized to contribute to risk of adverse outcomes including low birth weight and prematurity, possibly through its role as an antioxidant and/or in thyroid hormone function.&lt;h4>Objectives&lt;/h4>We assessed relationships between maternal selenium concentrations during pregnancy with offspring outcomes including birth measurements, low birth weight (&lt;2500 g), prematurity (&lt;37 wk), and small for gestational age (birth weight &lt;10th percentile for gestational age).&lt;h4>Methods&lt;/h4>This was a secondary analysis of the Women First Trial (NCT01883193), a randomized controlled study investigating the effect of small-quantity lipid-based nutrition supplement (sqLNS) with 130 μg selenium on fetal growth. sqLNS was started ≥3 mo prior to conception,</pubmed_abstract><journal>The Journal of nutrition</journal><pubmed_title>A Multicountry Analysis of Maternal Selenium Status in Pregnancy and Lactation and Infant Birth Outcomes: Findings from the Women First Maternal Preconception Study.</pubmed_title><pmcid>PMC12863136</pmcid><funding_grant_id>U10 HD076474</funding_grant_id><pubmed_authors>Garces A</pubmed_authors><pubmed_authors>Westcott JL</pubmed_authors><pubmed_authors>Goldenberg RL</pubmed_authors><pubmed_authors>Goudar S</pubmed_authors><pubmed_authors>McClure EM</pubmed_authors><pubmed_authors>Long JM</pubmed_authors><pubmed_authors>Shankar K</pubmed_authors><pubmed_authors>Saleem S</pubmed_authors><pubmed_authors>Gilley SP</pubmed_authors><pubmed_authors>Hambidge KM</pubmed_authors><pubmed_authors>Women First Trial Group</pubmed_authors><pubmed_authors>Somannavar MS</pubmed_authors><pubmed_authors>Krebs NF</pubmed_authors><pubmed_authors>Das A</pubmed_authors><pubmed_authors>Ali SA</pubmed_authors><pubmed_authors>Kemp JF</pubmed_authors><pubmed_authors>Derman Lester Figueroa RJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>A Multicountry Analysis of Maternal Selenium Status in Pregnancy and Lactation and Infant Birth Outcomes: Findings from the Women First Maternal Preconception Study.</name><description>&lt;h4>Background&lt;/h4>Maternal selenium deficiency is hypothesized to contribute to risk of adverse outcomes including low birth weight and prematurity, possibly through its role as an antioxidant and/or in thyroid hormone function.&lt;h4>Objectives&lt;/h4>We assessed relationships between maternal selenium concentrations during pregnancy with offspring outcomes including birth measurements, low birth weight (&lt;2500 g), prematurity (&lt;37 wk), and small for gestational age (birth weight &lt;10th percentile for gestational age).&lt;h4>Methods&lt;/h4>This was a secondary analysis of the Women First Trial (NCT01883193), a randomized controlled study investigating the effect of small-quantity lipid-based nutrition supplement (sqLNS) with 130 μg selenium on fetal growth. sqLNS was started ≥3 mo prior to conception,</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Feb</publication><modification>2026-07-16T03:11:39.218Z</modification><creation>2026-07-09T10:30:52.122Z</creation></dates><accession>S-EPMC12863136</accession><cross_references><pubmed>41461273</pubmed><doi>10.1016/j.tjnut.2025.101279</doi></cross_references></HashMap>